1 Borenstein JT.Intracochlear drug delivery systems[J].Expert Opin Drug Deliv,2011,8:1161.

2 Swan EE,Mescher MJ,Sewell WF,et al.Inner ear drug delivery for auditory applications[J].Adv Drug Deliv Rev,2008,60:1583.

3 Pararas EE,Borkholder DA,Borenstein JT.Microsystems technologies for drug delivery to the inner ear[J].Adv Drug Deliv Rev,2012,64:1650.

4 Shepherd RK,Xu J.A multichannel scala tympani electrode array incorporating a drug delivery system for chronic intracochlear infusion[J].Hear Res,2002,172:92.

5 Huon LK,Fang TY,Wang PC.Outcomes of intratympanic gentamicin injection to treat Meniere's disease[J].Otol Neurotol,2012,33:706.

6 Salt AN,Plontke SK.Principles of local drug delivery to the inner ear[J].Audiol Neurootol,2009,14:350.

7 戴春富,张国明,张茹,等.小剂量庆大霉素鼓室内注射治疗难治性梅尼埃病眩晕的临床研究[J].临床耳鼻咽喉头颈外科杂志,2007,21:151.

8 Borkholder DA.State-of-the-art mechanisms of intracochlear drug delivery[J].Curr Opin Otolaryngol Head Neck Surg,2008,16:472.

9 Hu A,Parnes LS.Intratympanic steroids for inner ear disorders:a review[J].Audiol Neurootol,2009,14:373.

10 Quaglieri S,Gatti O,Rebecchi E,et al.Intratympanic gentamicin treatment'as needed'for Meniere's disease.Longterm analysis using the Kaplan-Meier method[J].Eur Arch Otorhinolaryngol,2013,DOI 10.1007/s00405-013-2597-7.http://link.springer.com/content/pdf/10.1007%2 Fs00405-013-2597-7.pdf

11 Zhai F,Liu JP,Dai CF,et al.Evidence-based modification of intratympanic gentamicin injections in patients with intractable vertigo[J].Otol Neurotol,2010,31:642.

12 Herraiz C,Miguel AJ,Plaza G.Intratympanic drug delivery for the treatment of inner ear diseases[J].Acta Otorrinolaringol Esp,2010,61:225.

13 Christian DA,Cai S,Bowen DM,et al.Polymersome carriers:from self-assembly to siRNA and protein therapeutics[J].Eur J Pharm Biopharm,2009,71:463.

14 Levine DH,Ghoroghchian PP,Freudenberg J,et al.Polymersomes:a new multi-functional tool for cancer diagnosis and therapy[J].Methods,2008,46:25.

15 Chandrawati R,Caruso F.Biomimetic liposome-and polymersome-based multicompartmentalized assemblies[J].Langmuir,2012,28:13798.

16 PyykkI,Zou J,Zhang W,et al.Nanoparticle-based delivery for the treatment of inner ear disorders[J].Curr Opin Otolaryngol Head Neck Surg,2011,19:388.

17 吴丽媛,牟颖,施维,等.聚合物囊泡在生物医学领域中的应用[J].医学分子生物学杂志,2011,08:443.

18 Qiao ZY,Ji R,Huang XN,et al.Polymersomes from dual responsive block copolymers:drug encapsulation by heating and Acid-triggered release[J].Biomacromolecules,2013,14:1555.

19 Salt AN,King EB,Hartsock JJ,et al.Marker entry into vestibular perilymph via the stapes following applications to the round window niche of guinea pigs[J].Hear Res,2012,283:14.

20 King EB,Salt AN,Eastwood HT,et al.Direct entry of gadolinium into the vestibule following intratympanic applications in Guinea pigs and the influence of cochlear implantation[J].J Assoc Res Otolaryngol,2011,12:741.

21 Goycoolea MV,Lundman L.Round window membrane.Structure function and permeability:a review[J].Microsc Res Tech,1997,36:201.

22 Goycoolea MV.Clinical aspects of round window membrane permeability under normal and pathological conditions[J].Acta Otolaryngol,2001,121:437.

23 Zou J,Sood R,Ranjan S,et al.Manufacturing and in vivo inner ear visualization of MRI traceable liposome nanoparticles encapsulating gadolinium[J].J Nanobiotechnology,2010,8:32.

24 Zhang Y,Zhang W,Johnston AH,et al.Improving the visualization of fluorescently tagged nanoparticles and fluorophore-labeled molecular probes by treatment with CuSO4to quench autofluorescence in the rat inner ear[J].Hear Res,2010,269:1.

25 BuckiováD,Ranjan S,Newman TA,et al.Minimally invasive drug delivery to the cochlea through application of nanoparticles to the round window membrane[J].Nanomedicine(Lond),2012,7:1339.

26 Zhang Y,Zhang W,Johnston AH,et al.Comparison of the distribution pattern of PEG-b-PCL polymersomes delivered into the rat inner ear via different methods[J].Acta Otolaryngol,2011,131:1249.

27 Roy S,Johnston AH,Newman TA,et al.Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-derived peptide ligand:potential tool for drug delivery[J].Int J Pharm,2010,390:214.

28 Zhang Y,Zhang W,Johnston AH,et al.Targeted delivery of Tet1peptide functionalized polymersomes to the rat cochlear nerve[J].Int J Nanomedicine,2012,7:1015.

29 Beurg M,Tan X,Fettiplace R.A prestin motor in chicken auditory hair cells:Active force generation in a nonmammalian species[J].Neuron,2013,79:69.

30 Mistrík P,Daudet N,Morandell K,et al.Mammalian prestin is a weak Cl-/HCO-3electrogenic antiporter[J].J Physiol,2012,590:5597.

31 Surovtseva EV,Johnston AH,Zhang W,et al.Prestin binding peptides as ligands for targeted polymersome mediated drug delivery to outer hair cells in the inner ear[J].Int J Pharm,2012,424:121.

32 Shapiro B,Dormer K,Rutel IB.A two-magnet system to push therapeutic nanoparticles[J].AIP Conf Proc,2010,1311:77.

33 Katz JS,Levine DH,Davis KP,et al.Membrane stabilization of biodegradable polymersomes[J].Langmuir,2009,25:4429.

34 Oliveira H,Pérez-Andrés E,Thevenot J,et al.Magnetic field triggered drug release from polymersomes for cancer therapeutics[J].J Control Release,2013,169:165.

35 Li R,Li X,Xie L,et al.Preparation and evaluation of PEG-PCL nanoparticles for local tetradrine delivery[J].Int J Pharm,2009,379:158.

36 Ukawala M,Rajyaguru T,Chaudhari K,et al.Investigation on design of stable etoposide-loaded PEG-PCL micelles:effect of molecular weight of PEG-PCL diblock copolymer on the in vitro and in vivo performance of micelles[J].Drug Deliv,2012,19:155.

37 Battaglia G,Ryan AJ.Pathways of polymeric vesicle formation[J].J Phys Chem B,2006,110:10272.

38 Wang L,Chierico L,Little D,et al.Encapsulation of biomacromolecules within polymersomes by electroporation[J].Angew Chem Int Ed Engl,2012,51:11122.